Management of the difficult sentinel lymph node in patients with primary cutaneous melanoma

Annals of Plastic Surgery

Volumn 62, Issue 5, 2009, Pages 564-569

  Silverio, Amanda M ^a   McRae, Matthew C ^a   Ariyan, Stephan ^a   Narayan, Deepak ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Interval nodes; Intraoperative gamma probe; Lymphoscintigraphy; Melanoma; Sentinel lymph node; Vital blue dye

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPH VESSEL; LYMPHATIC DRAINAGE; MALE; MELANOMA; PRIMARY TUMOR; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; CASE REPORT; HEAD AND NECK TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; NECK; PATHOLOGY; SCINTISCANNING; SKIN TUMOR;

ADULT; AGED; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NECK; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 67449158928     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e3181a395e2     Document Type: Article

References (21)

1. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16:2253-2260.
2. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-983. (Pubitemid 29109331)
3. Kettlewell S, Moyes C, Bray C, et al. Value of sentinel node status as a prognostic factor in melanoma: prospective observational study. BMJ. 2006;332:1423. (Pubitemid 44365321)
4. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Eng J Med. 2006;355:1307-1317. (Pubitemid 44465459)
5. Gogas H, Ioannovich J, Dafni U, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Eng J Med. 2006;354:709-718. (Pubitemid 43247141)
6. Kirkwood JM, Tarhini AA. Adjuvant high-dose interferon-alpha therapy for high-risk melanoma. Forum (Genoa). 2003;13:127-140; quiz 187-1128
7. Wasserberg N, Tulchinsky H, Schachter J, et al. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free. Eur J Surg Oncol. 2004;30:851-856. (Pubitemid 39186072)
8. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302-311; discussion 311-1303
9. Jansen L, Koops HS, Nieweg OE, et al. Sentinel node biopsy for melanoma in the head and neck region. Head Neck. 2000;22:27-33. (Pubitemid 30030666)
10. Maccauro M, Villano C, Aliberti G, et al. Lymphoscintigraphy with intraoperative gamma probe sentinel node detection: clinical impact in patients with head and neck melanomas. Q J Nucl Med Mol Imaging. 2005;49:245-251. (Pubitemid 41569512)
11. Willis AI, Ridge JA. Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head Neck. 2007;29:979-985.
12. Tanis PJ, Nieweg OE, van den Brekel MW, et al. Dilemma of clinically node-negative head and neck melanoma: outcome of "watch and wait" policy, elective lymph node dissection, and sentinel node biopsy-a systematic review. Head Neck. 2008;30:380-389.
13. Rasgon BM. Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study. Laryngoscope. 2001;111:1366-1372.
14. Thompson JF, Uren RF, Shaw HM, et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg. 1999;189:195-204. (Pubitemid 29364693)
15. Sumner WE III, Ross MI, Mansfield PF, et al. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma. Cancer. 2002;95:354-360.
16. Uren RF, Howman-Giles R, Thompson JF, et al. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg. 2000;135:1168-1172. (Pubitemid 30750306)
17. Vidal-Sicart S, Pons F, Fuertes S, et al. Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary? Eur J Nucl Med Mol Imaging. 2004;31:945-949. (Pubitemid 38915648)
18. McMasters KM, Chao C, Wong SL, et al. Interval sentinel lymph nodes in melanoma. Arch Surg. 2002;137:543-547; discussion 547-549. (Pubitemid 34477695)
19. Roozendaal GK, de Vries JD, van Poll D, et al. Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg. 2001;88:305-308. (Pubitemid 32142724)
20. McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 2004;86:212-223. (Pubitemid 38880288)
21. Uren RF, Howman-Giles RB, Thompson JF, et al. Lymphatic drainage from peri-umbilical skin to internal mammary nodes. Clin Nucl Med. 1995;20:254-255.